(XMME) Xtrackers MSCI Emerging - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Etf • ISIN: IE00BTJRMP35 • Global Emerging Markets Equity

XMME: Stocks, Bonds, Emerging Markets, Equities

The Xtrackers MSCI Emerging Markets UCITS ETF 1C CHF (SW:XMME) is a compelling option for those seeking exposure to emerging markets. As part of the Xtrackers suite managed by DWS, it offers a structured approach to accessing high-growth regions. Domiciled in Ireland, it benefits from a regulatory environment thats favorable for European ETFs, providing a stable foundation for investors.

This ETF tracks the Morningstar EM TME NR USD index, which encompasses a diverse range of large and mid-cap companies across various emerging markets. By spreading investments across multiple countries and sectors, it mitigates risk through diversification, a key consideration for any investor entering these dynamic but volatile markets.

With an AUM of 5733.81M CHF, this fund is well-established, indicating a level of investor confidence and liquidity. Its passively managed structure ensures lower fees, aligning with the cost-effective approach that many investors prefer. However, its crucial to recognize that emerging markets can experience significant volatility, making it essential for investors to assess their risk tolerance and investment horizon carefully.

For those considering this ETF, understanding the underlying index is paramount. Additionally, the CHF denomination necessitates consideration of currency risks, as the funds performance is influenced by fluctuations between the Swiss Franc and the US Dollar. A long-term perspective is advisable, allowing investors to navigate the inherent volatility and capture potential growth over time.

Additional Sources for XMME ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

XMME ETF Overview

Market Cap in USD 6,779m
Category Global Emerging Markets Equity
TER 0.18%
IPO / Inception 2017-06-21

XMME ETF Ratings

Growth 5y 20.5%
Fundamental -
Dividend 0.0%
Rel. Strength Industry 3.73
Analysts -
Fair Price Momentum 46.75 CHF
Fair Price DCF -

XMME Dividends

No Dividends Paid

XMME Growth Ratios

Growth Correlation 3m 55.1%
Growth Correlation 12m 61.8%
Growth Correlation 5y -18.6%
CAGR 5y 7.11%
CAGR/Max DD 5y 0.21
Sharpe Ratio 12m 0.89
Alpha 1.95
Beta 0.72
Volatility 19.77%
Current Volume 58.2k
Average Volume 20d 27.6k
What is the price of XMME stocks?
As of March 14, 2025, the stock is trading at CHF 51.95 with a total of 58,248 shares traded.
Over the past week, the price has changed by -1.52%, over one month by -2.51%, over three months by -0.15% and over the past year by +9.55%.
Is Xtrackers MSCI Emerging a good stock to buy?
Neither. Based on ValueRay Analyses, Xtrackers MSCI Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.51 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XMME as of March 2025 is 46.75. This means that XMME is currently overvalued and has a potential downside of -10.01%.
Is XMME a buy, sell or hold?
Xtrackers MSCI Emerging has no consensus analysts rating.
What are the forecast for XMME stock price target?
According to ValueRays Forecast Model, XMME Xtrackers MSCI Emerging will be worth about 52 in March 2026. The stock is currently trading at 51.95. This means that the stock has a potential upside of +0.13%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 52 0.1%